What would you define as the west? I assume you would include Canada and the U.S. Would you also include Europe? Australia? Any former Soviet countries?
USA, Canada and Western Europe (the traditional developed world). If there was a solid reason to include Australia that might work, but I don't know too much about clinical trials over there.
My estimate of the sale price would be $.40 to $.50, which would leave most of us in the red, in my opinion.
I think $1.50 should be a minimum price target in a buyout. Even that is only a $170 million enterprise value. Would be a reasonable valuation for both sides... But, I agree with you that we can't get there from here with just a buyout. Much too high of a premium.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.